1. Home
  2. QTRX vs SCM Comparison

QTRX vs SCM Comparison

Compare QTRX & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$6.50

Market Cap

306.0M

Sector

Industrials

ML Signal

HOLD

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

HOLD

Current Price

$12.93

Market Cap

397.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
SCM
Founded
2007
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Finance/Investors Services
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
306.0M
397.8M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
QTRX
SCM
Price
$6.50
$12.93
Analyst Decision
Hold
Hold
Analyst Count
3
1
Target Price
$11.33
$13.00
AVG Volume (30 Days)
622.5K
153.1K
Earning Date
03-16-2026
03-03-2026
Dividend Yield
N/A
10.54%
EPS Growth
N/A
N/A
EPS
N/A
1.09
Revenue
$130,203,000.00
$102,538,895.00
Revenue This Year
N/A
N/A
Revenue Next Year
$28.28
N/A
P/E Ratio
N/A
$11.80
Revenue Growth
N/A
N/A
52 Week Low
$4.05
$11.19
52 Week High
$10.28
$15.56

Technical Indicators

Market Signals
Indicator
QTRX
SCM
Relative Strength Index (RSI) 43.71 51.64
Support Level $6.84 $12.57
Resistance Level $7.45 $13.21
Average True Range (ATR) 0.57 0.29
MACD -0.05 -0.03
Stochastic Oscillator 2.95 36.73

Price Performance

Historical Comparison
QTRX
SCM

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

Share on Social Networks: